TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/09/2026
Back to search
Official data from USPTO
THE JOURNAL OF CLINICAL HYPERTENSION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
THE JOURNAL OF CLINICAL HYPERTENSION
ST13
US500000078367348Class
16
Filing
78367348
Registration
2956164
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
03/11/2026
Trademark type
Word
Nice classes
16
Filing date
02/12/2004
Registration date
05/24/2005
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/11/2025
Last transaction
03/11/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
First use anywhere
1999-07-00
First use in commerce
1999-07-00
Drawing code
4
Owner type
03
Owner location
HOBOKEN, NJ, US
Examiner
LORENZO, ROBERT
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
JOHN WILEY & SONS, INC.
LE JACQ LTD.
Le Jacq Communications, Inc.
Representatives
Jeffrey R. Cadwell DORSEY & WHITNEY LLP
Technical classification
Nice Classes
Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
series of journals on the subject of the treatment of hypertension
Publications
History of USPTO decisions and trademark events.
40 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/09/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/09/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/09/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/09/2026
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/11/2025
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
08/11/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/11/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
03/28/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/24/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/13/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/13/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/13/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/13/2015
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/27/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/27/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
05/26/2015
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/27/2011
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
08/27/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/27/2011
ES8R
TEAS SECTION 8 RECEIVED
08/19/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/17/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/17/2007
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/12/2007
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/12/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/18/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/09/2007
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/08/2007
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/24/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/19/2005
ALIE
ASSIGNED TO LIE
02/18/2005
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
02/17/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
02/17/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/03/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/03/2005
GNRT
NON-FINAL ACTION E-MAILED
09/03/2004
CNRT
NON-FINAL ACTION WRITTEN
09/03/2004
DOCK
ASSIGNED TO EXAMINER
09/03/2004
NWAP
NEW APPLICATION ENTERED
02/27/2004
Continuous trademark protection
Get notified about every new filing that threatens THE JOURNAL OF CLINICAL HYPERTENSION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.